Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-117745
Filing Date
2024-11-13
Accepted
2024-11-13 16:30:25
Documents
1
Group Members
DAVID ROSEN

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm2427812d9_sc13ga.htm SC 13G/A 70639
  Complete submission text file 0001104659-24-117745.txt   72336
Mailing Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017
Business Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017 2124181881
Rubric Capital Management LP (Filed by) CIK: 0001687509 (see all company filings)

EIN.: 300934659 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ
Business Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ 7814319100
Kiniksa Pharmaceuticals International, plc (Subject) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90491 | Film No.: 241454875
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)